Cengild Medical Bhd

Cengild Medical Bhd EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Cengild Medical Bhd (CENGILD.KL) as of Oct 27, 2026 is -3.97. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -10.87 — a change of -63.48% (higher).

EV/FCF

-3.97

YoY

-63.48%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Cengild Medical Bhd is 2026 -3.97 . EV/FCF (Enterprise Value to Free Cash Flow) of Cengild Medical Bhd was 2025 -10.87 . It decreases by -63.48% higher compared to the previous year.

The Cengild Medical Bhd EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
37.99 MYR
Jan 1, 2020
17.82 MYR
Jan 1, 2021
14.87 MYR
Jan 1, 2022
13.75 MYR
Jan 1, 2023
16.11 MYR
Jan 1, 2024
-66.97 MYR
Jan 1, 2025
-10.87 MYR
Jan 1, 2026
-3.97 MYR
The Cengild Medical Bhd EV/FCF history
YEAREV/FCFYoY
-3.97-63.48%
-10.87-83.77%
-66.97-515.72%
16.11+17.14%
13.75-7.54%
14.87-16.54%
17.82-53.09%
37.99-81.21%
202.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cengild Medical Bhd Stock analysis

What does Cengild Medical Bhd do? Cengild Medical Bhd. provides specialized healthcare services focused on gastrointestinal and liver diseases, as well as obesity treatment. The company operates a medical center with 28 licensed beds, two operating theatres, three endoscopy suites, and imaging facilities including CT scans and ERCP equipment. Its services include consultant services, medical management, nursing, clinical support, 24-hour emergency care, health screenings, physiotherapy, and histopathology. The firm's subsidiaries, Cengild Sdn. Bhd. and Galen Primer Sdn. Bhd., support its healthcare operations. The company generates revenue through its medical center's diagnostic and therapeutic services, including outpatient emergency care, health screenings, and specialized treatments. Revenue streams are derived from patient consultations, endoscopic procedures, imaging services, and ancillary services like physiotherapy and histopathology. The primary customer segments are patients requiring gastrointestinal, liver, or obesity-related care, as well as those seeking health screenings and emergency medical services. Cengild Medical Bhd. serves both private patients and those requiring specialized medical management, leveraging its 36,588 sq. ft. facility to provide comprehensive care. The business model relies on high-volume outpatient services and specialized procedures to drive revenue, with subsidiaries handling operational aspects of the healthcare delivery. Cengild Medical Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cengild Medical Bhd stock

EV/FCF (Enterprise Value to Free Cash Flow) of Cengild Medical Bhd is -3.97 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Cengild Medical Bhd changed from -10.87 to -3.97, representing a -63.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Cengild Medical Bhd since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Cengild Medical Bhd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cengild Medical Bhd

All Key Metrics — Cengild Medical Bhd